| regulation of protein transport | GO:0051223 | 163 | 0.157 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.151 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.149 | |
| activation of adenylate cyclase activity | GO:0007190 | 4 | 0.123 | |
| blood circulation | GO:0008015 | 195 | 0.117 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.110 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.106 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.101 | |
| lymphocyte mediated immunity | GO:0002449 | 139 | 0.100 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.100 | |
| nucleotide biosynthetic process | GO:0009165 | 78 | 0.100 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.097 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.097 | |
| innate immune response | GO:0045087 | 157 | 0.096 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.095 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.095 | |
| regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002822 | 87 | 0.094 | |
| stem cell differentiation | GO:0048863 | 268 | 0.092 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.090 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.087 | |
| dna metabolic process | GO:0006259 | 303 | 0.085 | |
| anion transport | GO:0006820 | 177 | 0.083 | |
| purine nucleotide biosynthetic process | GO:0006164 | 65 | 0.083 | |
| gland development | GO:0048732 | 330 | 0.083 | |
| transmembrane transport | GO:0055085 | 412 | 0.081 | |
| regulation of defense response | GO:0031347 | 233 | 0.080 | |
| chemotaxis | GO:0006935 | 247 | 0.080 | |
| regulation of cell migration | GO:0030334 | 219 | 0.079 | |
| immune effector process | GO:0002252 | 321 | 0.076 | |
| positive regulation of cell migration | GO:0030335 | 109 | 0.076 | |
| positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002824 | 61 | 0.076 | |
| cell cell recognition | GO:0009988 | 44 | 0.076 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.073 | |
| positive regulation of purine nucleotide metabolic process | GO:1900544 | 114 | 0.072 | |
| positive regulation of secretion | GO:0051047 | 130 | 0.072 | |
| cation homeostasis | GO:0055080 | 212 | 0.071 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.069 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.068 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.068 | |
| regulation of leukocyte mediated immunity | GO:0002703 | 104 | 0.066 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.064 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.064 | |
| anion transmembrane transport | GO:0098656 | 71 | 0.063 | |
| adaptive immune response | GO:0002250 | 155 | 0.062 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.061 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.061 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.059 | |
| amine metabolic process | GO:0009308 | 45 | 0.058 | |
| purine ribonucleotide biosynthetic process | GO:0009152 | 59 | 0.058 | |
| g protein coupled receptor internalization | GO:0002031 | 3 | 0.058 | |
| forebrain development | GO:0030900 | 302 | 0.058 | |
| purine containing compound biosynthetic process | GO:0072522 | 70 | 0.057 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.056 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.056 | |
| gtp metabolic process | GO:0046039 | 144 | 0.056 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.056 | |
| adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002460 | 145 | 0.055 | |
| fertilization | GO:0009566 | 127 | 0.054 | |
| positive regulation of cytokine production | GO:0001819 | 174 | 0.054 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.053 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.053 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.052 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.052 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.051 | |
| positive regulation of glycolytic process | GO:0045821 | 4 | 0.051 | |
| cellular homeostasis | GO:0019725 | 240 | 0.050 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.050 | |
| translation | GO:0006412 | 93 | 0.050 | |
| positive regulation of defense response | GO:0031349 | 124 | 0.050 | |
| nucleoside phosphate biosynthetic process | GO:1901293 | 79 | 0.049 | |
| ribose phosphate biosynthetic process | GO:0046390 | 59 | 0.048 | |
| mapk cascade | GO:0000165 | 281 | 0.047 | |
| action potential | GO:0001508 | 78 | 0.045 | |
| ameboidal type cell migration | GO:0001667 | 128 | 0.045 | |
| positive regulation of adaptive immune response | GO:0002821 | 61 | 0.045 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.044 | |
| cellular divalent inorganic cation homeostasis | GO:0072503 | 127 | 0.044 | |
| adenylate cyclase modulating g protein coupled receptor signaling pathway | GO:0007188 | 54 | 0.044 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.044 | |
| organophosphate biosynthetic process | GO:0090407 | 122 | 0.043 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.043 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.043 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.043 | |
| pallium development | GO:0021543 | 120 | 0.042 | |
| transforming growth factor beta secretion | GO:0038044 | 1 | 0.042 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.041 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.040 | |
| phospholipase c activating serotonin receptor signaling pathway | GO:0007208 | 1 | 0.040 | |
| ossification | GO:0001503 | 216 | 0.040 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.040 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.040 | |
| transmission of nerve impulse | GO:0019226 | 76 | 0.040 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.040 | |
| gastrin induced gastric acid secretion | GO:0001698 | 1 | 0.040 | |
| cytokine production | GO:0001816 | 319 | 0.039 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.038 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.038 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.038 | |
| fat cell differentiation | GO:0045444 | 160 | 0.038 | |
| cation transport | GO:0006812 | 399 | 0.037 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.037 | |
| leukocyte mediated immunity | GO:0002443 | 174 | 0.037 | |
| negative regulation of immune effector process | GO:0002698 | 55 | 0.037 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.037 | |
| positive regulation of secretion by cell | GO:1903532 | 114 | 0.036 | |
| gliogenesis | GO:0042063 | 141 | 0.036 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.036 | |
| sequestering of calcium ion | GO:0051208 | 18 | 0.036 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 159 | 0.036 | |
| g protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger | GO:0007187 | 55 | 0.035 | |
| single fertilization | GO:0007338 | 82 | 0.035 | |
| angiogenesis | GO:0001525 | 201 | 0.035 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.035 | |
| cellular response to lipid | GO:0071396 | 145 | 0.035 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.034 | |
| developmental growth involved in morphogenesis | GO:0060560 | 138 | 0.034 | |
| regulation of system process | GO:0044057 | 200 | 0.034 | |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.034 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.034 | |
| cellular calcium ion homeostasis | GO:0006874 | 119 | 0.034 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.034 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.033 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.033 | |
| retina development in camera type eye | GO:0060041 | 119 | 0.033 | |
| histamine induced gastric acid secretion | GO:0001697 | 1 | 0.033 | |
| positive regulation of camp metabolic process | GO:0030816 | 19 | 0.033 | |
| regulation of innate immune response | GO:0045088 | 91 | 0.033 | |
| regulation of synaptic growth at neuromuscular junction | GO:0008582 | 4 | 0.033 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.032 | |
| chloride transport | GO:0006821 | 32 | 0.032 | |
| production of molecular mediator of immune response | GO:0002440 | 103 | 0.032 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.032 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.032 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.031 | |
| tissue homeostasis | GO:0001894 | 115 | 0.031 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.031 | |
| negative regulation of growth | GO:0045926 | 99 | 0.031 | |
| hormone metabolic process | GO:0042445 | 86 | 0.031 | |
| humoral immune response | GO:0006959 | 57 | 0.031 | |
| regulation of secretion | GO:0051046 | 274 | 0.031 | |
| positive regulation of nucleotide metabolic process | GO:0045981 | 114 | 0.031 | |
| immune response activating signal transduction | GO:0002757 | 116 | 0.030 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.030 | |
| regulation of cell division | GO:0051302 | 76 | 0.030 | |
| positive regulation of the force of heart contraction by epinephrine norepinephrine | GO:0001997 | 3 | 0.030 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.030 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.029 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.029 | |
| cytokine mediated signaling pathway | GO:0019221 | 115 | 0.029 | |
| positive regulation of protein transport | GO:0051222 | 93 | 0.029 | |
| nucleocytoplasmic transport | GO:0006913 | 139 | 0.029 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.029 | |
| regulation of lymphocyte mediated immunity | GO:0002706 | 84 | 0.029 | |
| ribonucleotide biosynthetic process | GO:0009260 | 59 | 0.029 | |
| myotube differentiation | GO:0014902 | 105 | 0.029 | |
| c21 steroid hormone biosynthetic process | GO:0006700 | 3 | 0.029 | |
| negative regulation of defense response | GO:0031348 | 77 | 0.028 | |
| cyclic purine nucleotide metabolic process | GO:0052652 | 43 | 0.028 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.028 | |
| symbiosis encompassing mutualism through parasitism | GO:0044403 | 83 | 0.028 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.028 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.028 | |
| regulation of serotonin secretion | GO:0014062 | 3 | 0.028 | |
| positive regulation of nucleotide biosynthetic process | GO:0030810 | 26 | 0.028 | |
| multicellular organism growth | GO:0035264 | 161 | 0.028 | |
| cell activation involved in immune response | GO:0002263 | 126 | 0.028 | |
| neural precursor cell proliferation | GO:0061351 | 121 | 0.028 | |
| camp biosynthetic process | GO:0006171 | 31 | 0.028 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.028 | |
| positive regulation of t cell receptor signaling pathway | GO:0050862 | 4 | 0.028 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.027 | |
| activation of immune response | GO:0002253 | 138 | 0.027 | |
| lymphocyte activation involved in immune response | GO:0002285 | 93 | 0.027 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.027 | |
| vasodilation by norepinephrine epinephrine involved in regulation of systemic arterial blood pressure | GO:0002025 | 3 | 0.027 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.027 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.027 | |
| regulation of leukocyte differentiation | GO:1902105 | 159 | 0.027 | |
| positive regulation of kinase activity | GO:0033674 | 155 | 0.026 | |
| reactive nitrogen species metabolic process | GO:2001057 | 0 | 0.026 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.026 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.026 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.026 | |
| adenylate cyclase activating g protein coupled receptor signaling pathway | GO:0007189 | 30 | 0.026 | |
| positive regulation of immune effector process | GO:0002699 | 107 | 0.026 | |
| telencephalon development | GO:0021537 | 186 | 0.026 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.026 | |
| guanosine containing compound catabolic process | GO:1901069 | 144 | 0.025 | |
| intracellular protein transport | GO:0006886 | 204 | 0.025 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.025 | |
| cellular response to temperature stimulus | GO:0071502 | 2 | 0.025 | |
| guanosine containing compound metabolic process | GO:1901068 | 144 | 0.025 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.025 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.025 | |
| mature dendritic cell differentiation | GO:0097029 | 3 | 0.025 | |
| regulation of translation | GO:0006417 | 71 | 0.025 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.025 | |
| positive regulation of lymphocyte mediated immunity | GO:0002708 | 62 | 0.025 | |
| immune response regulating cell surface receptor signaling pathway | GO:0002768 | 80 | 0.025 | |
| oxidation reduction process | GO:0055114 | 342 | 0.025 | |
| positive regulation of cell activation | GO:0050867 | 158 | 0.025 | |
| regulation of tumor necrosis factor superfamily cytokine production | GO:1903555 | 50 | 0.025 | |
| positive regulation of transforming growth factor beta secretion | GO:2001203 | 1 | 0.024 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.024 | |
| negative regulation of homeostatic process | GO:0032845 | 71 | 0.024 | |
| maintenance of location | GO:0051235 | 89 | 0.024 | |
| habituation | GO:0046959 | 3 | 0.024 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.024 | |
| positive regulation of leukocyte mediated cytotoxicity | GO:0001912 | 31 | 0.024 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.024 | |
| nuclear transport | GO:0051169 | 139 | 0.024 | |
| regulation of symbiosis encompassing mutualism through parasitism | GO:0043903 | 52 | 0.023 | |
| cytosolic calcium ion homeostasis | GO:0051480 | 70 | 0.023 | |
| t cell extravasation | GO:0072683 | 4 | 0.023 | |
| regulation of lyase activity | GO:0051339 | 13 | 0.023 | |
| positive regulation of t cell extravasation | GO:2000409 | 2 | 0.023 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.023 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.023 | |
| regulation of cell motility | GO:2000145 | 236 | 0.023 | |
| calcium ion transport into cytosol | GO:0060402 | 48 | 0.023 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.023 | |
| protein kinase c activating g protein coupled receptor signaling pathway | GO:0007205 | 4 | 0.023 | |
| sequestering of metal ion | GO:0051238 | 19 | 0.023 | |
| regulation of blood circulation | GO:1903522 | 93 | 0.023 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.023 | |
| positive regulation of the force of heart contraction by chemical signal | GO:0003099 | 3 | 0.023 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.023 | |
| positive regulation of cellular catabolic process | GO:0031331 | 148 | 0.023 | |
| positive regulation of immunological synapse formation | GO:2000522 | 1 | 0.023 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.023 | |
| cofactor transport | GO:0051181 | 4 | 0.023 | |
| regulation of interleukin 10 secretion | GO:2001179 | 4 | 0.023 | |
| blastocyst development | GO:0001824 | 80 | 0.022 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.022 | |
| sperm motility | GO:0030317 | 47 | 0.022 | |
| chromatin organization | GO:0006325 | 206 | 0.022 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.022 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.022 | |
| conditioned taste aversion | GO:0001661 | 4 | 0.022 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.022 | |
| regulation of myeloid cell apoptotic process | GO:0033032 | 19 | 0.022 | |
| microtubule based process | GO:0007017 | 236 | 0.022 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 40 | 0.022 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.022 | |
| female sex differentiation | GO:0046660 | 84 | 0.022 | |
| positive regulation of heart rate by epinephrine norepinephrine | GO:0001996 | 4 | 0.022 | |
| regulation of peptide secretion | GO:0002791 | 77 | 0.021 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.021 | |
| regulation of purine nucleotide biosynthetic process | GO:1900371 | 34 | 0.021 | |
| positive regulation of glycoprotein biosynthetic process involved in immunological synapse formation | GO:2000526 | 1 | 0.021 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.021 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.021 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.021 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.021 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.021 | |
| regulation of vesicle mediated transport | GO:0060627 | 139 | 0.021 | |
| telencephalon cell migration | GO:0022029 | 55 | 0.021 | |
| positive regulation of gtpase activity | GO:0043547 | 85 | 0.021 | |
| protein import into nucleus | GO:0006606 | 95 | 0.020 | |
| positive regulation of purine nucleotide biosynthetic process | GO:1900373 | 26 | 0.020 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.020 | |
| regulation of monocyte extravasation | GO:2000437 | 2 | 0.020 | |
| defense response to bacterium | GO:0042742 | 119 | 0.020 | |
| protein catabolic process | GO:0030163 | 221 | 0.020 | |
| positive regulation of gtp catabolic process | GO:0033126 | 85 | 0.020 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.020 | |
| negative regulation of feeding behavior | GO:2000252 | 1 | 0.020 | |
| l amino acid transport | GO:0015807 | 32 | 0.020 | |
| viral process | GO:0016032 | 41 | 0.020 | |
| immunoglobulin production | GO:0002377 | 73 | 0.020 | |
| kidney development | GO:0001822 | 213 | 0.020 | |
| respiratory system development | GO:0060541 | 190 | 0.020 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.019 | |
| protein import | GO:0017038 | 101 | 0.019 | |
| regulation of inflammatory response | GO:0050727 | 147 | 0.019 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.019 | |
| positive regulation of cyclic nucleotide metabolic process | GO:0030801 | 24 | 0.019 | |
| cell fate commitment | GO:0045165 | 210 | 0.019 | |
| defense response to virus | GO:0051607 | 68 | 0.019 | |
| cyclic nucleotide biosynthetic process | GO:0009190 | 44 | 0.019 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.019 | |
| negative regulation of serotonin secretion | GO:0014063 | 2 | 0.019 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.019 | |
| skin development | GO:0043588 | 220 | 0.019 | |
| inorganic anion transport | GO:0015698 | 43 | 0.019 | |
| hypersensitivity | GO:0002524 | 10 | 0.019 | |
| regulation of adaptive immune response | GO:0002819 | 90 | 0.019 | |
| positive regulation of nucleoside metabolic process | GO:0045979 | 91 | 0.019 | |
| carbohydrate catabolic process | GO:0016052 | 32 | 0.019 | |
| organic hydroxy compound transport | GO:0015850 | 93 | 0.019 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.019 | |
| skeletal system development | GO:0001501 | 356 | 0.019 | |
| regulation of nucleotide biosynthetic process | GO:0030808 | 34 | 0.019 | |
| developmental maturation | GO:0021700 | 193 | 0.019 | |
| regulation of transforming growth factor beta secretion | GO:2001201 | 1 | 0.019 | |
| positive regulation of interferon gamma production | GO:0032729 | 39 | 0.019 | |
| positive regulation of cyclic nucleotide biosynthetic process | GO:0030804 | 24 | 0.018 | |
| regulation of ion homeostasis | GO:2000021 | 64 | 0.018 | |
| interspecies interaction between organisms | GO:0044419 | 83 | 0.018 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.018 | |
| inorganic ion transmembrane transport | GO:0098660 | 234 | 0.018 | |
| somatic diversification of immune receptors | GO:0002200 | 53 | 0.018 | |
| positive regulation of protein secretion | GO:0050714 | 52 | 0.018 | |
| development of primary female sexual characteristics | GO:0046545 | 73 | 0.018 | |
| regulation of cyclic nucleotide biosynthetic process | GO:0030802 | 31 | 0.018 | |
| regulation of cyclic nucleotide metabolic process | GO:0030799 | 40 | 0.018 | |
| negative regulation of angiogenesis | GO:0016525 | 25 | 0.018 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.018 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.018 | |
| positive regulation of reactive oxygen species biosynthetic process | GO:1903428 | 2 | 0.018 | |
| regulation of interferon gamma production | GO:0032649 | 57 | 0.018 | |
| neuronal action potential | GO:0019228 | 54 | 0.018 | |
| positive regulation of angiogenesis | GO:0045766 | 46 | 0.018 | |
| wound healing | GO:0042060 | 157 | 0.017 | |
| leukocyte activation involved in immune response | GO:0002366 | 126 | 0.017 | |
| forebrain cell migration | GO:0021885 | 58 | 0.017 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.017 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.017 | |
| regulation of lymphocyte proliferation | GO:0050670 | 117 | 0.017 | |
| positive regulation of lymphocyte activation | GO:0051251 | 140 | 0.017 | |
| release of sequestered calcium ion into cytosol | GO:0051209 | 42 | 0.017 | |
| sensitization | GO:0046960 | 2 | 0.017 | |
| regulation of hematopoietic stem cell migration | GO:2000471 | 1 | 0.017 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 147 | 0.017 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.017 | |
| cerebral cortex development | GO:0021987 | 86 | 0.017 | |
| regulation of leukocyte mediated cytotoxicity | GO:0001910 | 38 | 0.017 | |
| fat cell proliferation | GO:0070341 | 4 | 0.017 | |
| regulation of leukocyte proliferation | GO:0070663 | 121 | 0.017 | |
| immune response activating cell surface receptor signaling pathway | GO:0002429 | 72 | 0.017 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 126 | 0.017 | |
| nuclear import | GO:0051170 | 95 | 0.017 | |
| negative regulation of vasculature development | GO:1901343 | 26 | 0.017 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.017 | |
| glial cell differentiation | GO:0010001 | 131 | 0.017 | |
| cofactor metabolic process | GO:0051186 | 80 | 0.016 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.016 | |
| heart morphogenesis | GO:0003007 | 178 | 0.016 | |
| interleukin 12 secretion | GO:0072610 | 3 | 0.016 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.016 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.016 | |
| peptidyl tyrosine phosphorylation | GO:0018108 | 143 | 0.016 | |
| b cell mediated immunity | GO:0019724 | 71 | 0.016 | |
| stem cell development | GO:0048864 | 219 | 0.016 | |
| positive regulation of nucleotide catabolic process | GO:0030813 | 88 | 0.016 | |
| regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090092 | 112 | 0.016 | |
| response to peptide hormone | GO:0043434 | 127 | 0.016 | |
| regulation of type 2 immune response | GO:0002828 | 18 | 0.016 | |
| inflammatory response | GO:0006954 | 244 | 0.016 | |
| regulation of vasculature development | GO:1901342 | 88 | 0.016 | |
| myeloid cell homeostasis | GO:0002262 | 114 | 0.016 | |
| t helper 1 type immune response | GO:0042088 | 25 | 0.016 | |
| t helper 17 cell chemotaxis | GO:0035705 | 1 | 0.016 | |
| progesterone metabolic process | GO:0042448 | 4 | 0.016 | |
| serotonin receptor signaling pathway | GO:0007210 | 8 | 0.016 | |
| sulfur compound metabolic process | GO:0006790 | 100 | 0.016 | |
| response to acid chemical | GO:0001101 | 111 | 0.016 | |
| protein oligomerization | GO:0051259 | 67 | 0.015 | |
| positive regulation of ras gtpase activity | GO:0032320 | 65 | 0.015 | |
| central nervous system neuron differentiation | GO:0021953 | 162 | 0.015 | |
| regulation of camp metabolic process | GO:0030814 | 30 | 0.015 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.015 | |
| response to oxidative stress | GO:0006979 | 123 | 0.015 | |
| negative regulation of t helper 2 cell differentiation | GO:0045629 | 4 | 0.015 | |
| methylation | GO:0032259 | 134 | 0.015 | |
| viral life cycle | GO:0019058 | 36 | 0.015 | |
| helper t cell chemotaxis | GO:0035704 | 1 | 0.015 | |
| somatic diversification of immunoglobulins | GO:0016445 | 43 | 0.015 | |
| cell recognition | GO:0008037 | 83 | 0.015 | |
| cellular response to histamine | GO:0071420 | 1 | 0.015 | |
| exocytosis | GO:0006887 | 121 | 0.015 | |
| regulation of fat cell differentiation | GO:0045598 | 81 | 0.015 | |
| response to transforming growth factor beta | GO:0071559 | 88 | 0.015 | |
| regulation of cytokine secretion | GO:0050707 | 61 | 0.015 | |
| regulation of purine nucleotide catabolic process | GO:0033121 | 122 | 0.015 | |
| positive regulation of monocyte chemotaxis | GO:0090026 | 2 | 0.015 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.015 | |
| positive regulation of cyclase activity | GO:0031281 | 11 | 0.015 | |
| response to light stimulus | GO:0009416 | 135 | 0.015 | |
| gtp catabolic process | GO:0006184 | 143 | 0.015 | |
| cellular response to dna damage stimulus | GO:0006974 | 207 | 0.014 | |
| calcium ion transport | GO:0006816 | 159 | 0.014 | |
| positive regulation of lyase activity | GO:0051349 | 11 | 0.014 | |
| single organism nuclear import | GO:1902593 | 95 | 0.014 | |
| corticotropin releasing hormone secretion | GO:0043396 | 2 | 0.014 | |
| regulation of erk1 and erk2 cascade | GO:0070372 | 71 | 0.014 | |
| gonad development | GO:0008406 | 141 | 0.014 | |
| immune response regulating signaling pathway | GO:0002764 | 125 | 0.014 | |
| protein secretion | GO:0009306 | 111 | 0.014 | |
| dopamine receptor signaling pathway | GO:0007212 | 16 | 0.014 | |
| positive regulation of cytosolic calcium ion concentration | GO:0007204 | 65 | 0.014 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.014 | |
| regulation of t cell proliferation | GO:0042129 | 92 | 0.014 | |
| epithelial cell development | GO:0002064 | 159 | 0.014 | |
| dna recombination | GO:0006310 | 92 | 0.014 | |
| male gamete generation | GO:0048232 | 285 | 0.014 | |
| defense response to gram positive bacterium | GO:0050830 | 50 | 0.014 | |
| learning or memory | GO:0007611 | 148 | 0.014 | |
| locomotory behavior | GO:0007626 | 195 | 0.014 | |
| cyclic nucleotide metabolic process | GO:0009187 | 59 | 0.014 | |
| regulation of morphogenesis of a branching structure | GO:0060688 | 53 | 0.014 | |
| cd4 positive alpha beta t cell cytokine production | GO:0035743 | 4 | 0.014 | |
| sensory perception | GO:0007600 | 245 | 0.014 | |
| regulation of camp biosynthetic process | GO:0030817 | 25 | 0.014 | |
| coenzyme metabolic process | GO:0006732 | 52 | 0.014 | |
| male sex differentiation | GO:0046661 | 109 | 0.014 | |
| regulation of gtp catabolic process | GO:0033124 | 113 | 0.014 | |
| mineralocorticoid biosynthetic process | GO:0006705 | 1 | 0.014 | |
| positive regulation of neural precursor cell proliferation | GO:2000179 | 42 | 0.014 | |
| regulation of brown fat cell proliferation | GO:0070347 | 1 | 0.014 | |
| regulation of b cell mediated immunity | GO:0002712 | 37 | 0.014 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.014 | |
| positive regulation of leukocyte mediated immunity | GO:0002705 | 70 | 0.014 | |
| regulation of protein secretion | GO:0050708 | 82 | 0.014 | |
| tissue remodeling | GO:0048771 | 102 | 0.014 | |
| cellular response to lipopolysaccharide | GO:0071222 | 77 | 0.014 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.014 | |
| interleukin 10 secretion | GO:0072608 | 4 | 0.014 | |
| germ cell development | GO:0007281 | 185 | 0.014 | |
| camera type eye development | GO:0043010 | 266 | 0.013 | |
| negative regulation of multi organism process | GO:0043901 | 68 | 0.013 | |
| regulation of protein localization | GO:0032880 | 231 | 0.013 | |
| alpha amino acid metabolic process | GO:1901605 | 59 | 0.013 | |
| protein targeting | GO:0006605 | 143 | 0.013 | |
| regulation of monocyte chemotaxis | GO:0090025 | 3 | 0.013 | |
| digestive tract development | GO:0048565 | 190 | 0.013 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.013 | |
| somatic diversification of immune receptors via germline recombination within a single locus | GO:0002562 | 51 | 0.013 | |
| bone resorption | GO:0045453 | 38 | 0.013 | |
| salivary gland morphogenesis | GO:0007435 | 33 | 0.013 | |
| second messenger mediated signaling | GO:0019932 | 73 | 0.013 | |
| adrenergic receptor signaling pathway | GO:0071875 | 13 | 0.013 | |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.013 | |
| metanephros development | GO:0001656 | 79 | 0.013 | |
| cellular response to molecule of bacterial origin | GO:0071219 | 83 | 0.013 | |
| positive regulation of t cell proliferation | GO:0042102 | 52 | 0.013 | |
| positive regulation of interleukin 12 production | GO:0032735 | 21 | 0.013 | |
| muscle tissue development | GO:0060537 | 308 | 0.013 | |
| regulation of nucleotide catabolic process | GO:0030811 | 122 | 0.013 | |
| positive regulation of apoptotic signaling pathway | GO:2001235 | 95 | 0.013 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.013 | |
| positive regulation of stem cell proliferation | GO:2000648 | 59 | 0.013 | |
| energy reserve metabolic process | GO:0006112 | 39 | 0.013 | |
| negative regulation of macrophage apoptotic process | GO:2000110 | 3 | 0.013 | |
| stem cell proliferation | GO:0072089 | 117 | 0.013 | |
| positive regulation of proteasomal ubiquitin dependent protein catabolic process | GO:0032436 | 23 | 0.013 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.013 | |
| cell division | GO:0051301 | 120 | 0.013 | |
| nephron epithelium development | GO:0072009 | 92 | 0.013 | |
| glycoprotein metabolic process | GO:0009100 | 116 | 0.013 | |
| long term synaptic depression | GO:0060292 | 13 | 0.013 | |
| astrocyte development | GO:0014002 | 12 | 0.013 | |
| inflammatory response to antigenic stimulus | GO:0002437 | 30 | 0.013 | |
| peptide transport | GO:0015833 | 133 | 0.013 | |
| reactive oxygen species biosynthetic process | GO:1903409 | 8 | 0.013 | |
| muscle cell proliferation | GO:0033002 | 52 | 0.013 | |
| regulation of extrinsic apoptotic signaling pathway | GO:2001236 | 77 | 0.013 | |
| cell fate specification | GO:0001708 | 72 | 0.013 | |
| intestinal epithelial structure maintenance | GO:0060729 | 4 | 0.013 | |
| positive regulation of phospholipase c activity | GO:0010863 | 2 | 0.012 | |
| eosinophil activation | GO:0043307 | 1 | 0.012 | |
| interferon gamma production | GO:0032609 | 67 | 0.012 | |
| erk1 and erk2 cascade | GO:0070371 | 77 | 0.012 | |
| glucose homeostasis | GO:0042593 | 128 | 0.012 | |
| renal system development | GO:0072001 | 225 | 0.012 | |
| regulation of microvillus assembly | GO:0032534 | 3 | 0.012 | |
| positive regulation of epithelial cell proliferation | GO:0050679 | 68 | 0.012 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.012 | |
| regulation of systemic arterial blood pressure by norepinephrine epinephrine | GO:0001993 | 8 | 0.012 | |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.012 | |
| regulation of systemic arterial blood pressure | GO:0003073 | 61 | 0.012 | |
| developmental cell growth | GO:0048588 | 84 | 0.012 | |
| regulation of ras protein signal transduction | GO:0046578 | 114 | 0.012 | |
| positive regulation of cytosolic calcium ion concentration involved in phospholipase c activating g protein coupled signaling pathway | GO:0051482 | 4 | 0.012 | |
| regulation of production of molecular mediator of immune response | GO:0002700 | 65 | 0.012 | |
| dephosphorylation | GO:0016311 | 129 | 0.012 | |
| protein activation cascade | GO:0072376 | 19 | 0.012 | |
| negative regulation of t cell proliferation | GO:0042130 | 38 | 0.012 | |
| establishment of protein localization to organelle | GO:0072594 | 118 | 0.012 | |
| respiratory tube development | GO:0030323 | 167 | 0.012 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.012 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.012 | |
| cardiac muscle tissue growth involved in heart morphogenesis | GO:0003245 | 1 | 0.012 | |
| female gonad development | GO:0008585 | 71 | 0.012 | |
| regulation of fat cell proliferation | GO:0070344 | 4 | 0.012 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.012 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.012 | |
| response to radiation | GO:0009314 | 165 | 0.012 | |
| positive regulation of adenylate cyclase activity | GO:0045762 | 8 | 0.012 | |
| leukocyte migration | GO:0050900 | 124 | 0.012 | |
